Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Jupiter Life Line Hospitals Ltd (JLHL) Share Price & Fundamentals

Company Overview

Founded Year

2002

Listed Year

2023

Headquarter

Mumbai, Maharashtra, India

MD/CEO

Dr. Ajay Thakker

Website

https://www.jupiterhospital.com

Company Facts

What we do

Jupiter Life Line Hospitals Ltd is a leading multi-speciality tertiary and quaternary care healthcare provider in Western India, operating under the Jupiter brand with advanced medical technologies and 1,248 beds.

Founded in

2,002

Market share

Prominent provider in Mumbai metropolitan area and Western India, expanding capacity and specialties, establishing new hospitals.

Problem solved

Provides advanced medical treatments including organ transplants, oncology, cardiology, and robotic surgeries addressing complex healthcare needs.

Top clients or who we serve

Serves diverse patients across multiple specialties, focusing on tertiary and quaternary care including medical tourists; B2C and healthcare institutions.

Key management

Dr. Ajay Thakker (Chairman & Managing Director) and Dr. Ankit Thakker (Joint Managing Director & CEO).

Our journey and innovations

Founded in 2002; expanded from Thane hospital (2007) to Pune (2017) and Indore (2020); pioneered interstitial brachytherapy and complex transplant surgeries.

Where we operate

Hospitals located in Thane, Pune, Indore, and Dombivli; expansion ongoing in Pune and Thane, covering Western India.

Top products or what we offer

Advanced medical care in over 30 specialties including organ transplant, oncology, orthopaedics, cardiology, neurology, and precision treatments like robotic surgeries.

Top brands

Jupiter Hospitals with benchmark technologies e.g., ALLIA IGS 530 by GE HealthCare; flagship multi-speciality tertiary and quaternary care centers.

Raw materials needed

-

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue primarily from recurring patient services, elective surgeries, and healthcare treatments.

Our industry position

Leading multi-speciality hospital group in Western India, growing bed capacity and specialty care offerings with strong brand presence.

Financial highlights

FY 2025-26 consolidated revenue Rs.1,499.8 crores; net profit Rs.194 crores; steady revenue and profit growth year-on-year.

Geographical revenue split

-

Order book

-

Whats driving growth

Rising healthcare demand, expansion into new locations, advanced treatments, medical tourism, and increased bed capacity drive growth.

Our future plans

Opening new hospitals in Bibvewadi Pune (500 beds) and Mira Road Thane (300 beds), expanding ICU and operating theatres.

Our green promise

-

Our people and values

Committed to patient-first philosophy, innovation, ethical governance, and employee professionalism.

Key challenges ahead

Managing expansion, maintaining high-quality care, regulatory compliance, and competitive healthcare landscape.

Interesting facts

First in India to install ALLIA IGS 530 by GE HealthCare; performed pioneering organ transplant surgeries in Thane.

Risks and strategy

Mitigates operational, financial and regulatory risks via strong governance, compliance, and continual monitoring.

Market Footprint

Top Clients

Top Clients

Serves diverse patients across multiple specialties, focusing on tertiary and quaternary care including medical tourists; B2C and healthcare institutions.

Top Products

Top Products

Advanced medical care in over 30 specialties including organ transplant, oncology, orthopaedics, cardiology, neurology, and precision treatments like robotic surgeries.

Price Movement & Share Holding

Today's High/Low

252261.5

52 Week High/Low

233.4340
Past Returns

1 week

4.18%

1 month

-2.69%

3 month

-21.79%

1 year

-83.4%

3 year

-75.06%

5 year

-76.13%

Share Holding

Promoters

40.91%

FII

9.13%

DII

19.13%

Retail

23.58%

Others

7.26%

Company Overview

Founded Year

2002

Listed Year

2023

Headquarter

Mumbai, Maharashtra, India

MD/CEO

Dr. Ajay Thakker (Chairman & Managing Director) and Dr. Ankit Thakker (Joint Managing Director & CEO).

Website

https://www.jupiterhospital.com

Price Movement & Share Holding

Today's High/Low

252261.5

52 Week High/Low

233.4340

Past Returns

1 week

4.18%

1 month

-2.69%

3 month

-21.79%

1 year

-83.4%

3 year

-75.06%

5 year

-76.13%

Share Holding

Promoters

40.91%

FII

9.13%

DII

19.13%

Retail

23.58%

Others

7.26%

Company Facts

What we do

Jupiter Life Line Hospitals Ltd is a leading multi-speciality tertiary and quaternary care healthcare provider in Western India, operating under the Jupiter brand with advanced medical technologies and 1,248 beds.

Founded in

2002

Market share

Prominent provider in Mumbai metropolitan area and Western India, expanding capacity and specialties, establishing new hospitals.

Problem solved

Provides advanced medical treatments including organ transplants, oncology, cardiology, and robotic surgeries addressing complex healthcare needs.

Top clients or who we serve

Serves diverse patients across multiple specialties, focusing on tertiary and quaternary care including medical tourists; B2C and healthcare institutions.

Key management

Dr. Ajay Thakker (Chairman & Managing Director) and Dr. Ankit Thakker (Joint Managing Director & CEO).

Our journey and innovations

Founded in 2002; expanded from Thane hospital (2007) to Pune (2017) and Indore (2020); pioneered interstitial brachytherapy and complex transplant surgeries.

Where we operate

Hospitals located in Thane, Pune, Indore, and Dombivli; expansion ongoing in Pune and Thane, covering Western India.

Top products or what we offer

Advanced medical care in over 30 specialties including organ transplant, oncology, orthopaedics, cardiology, neurology, and precision treatments like robotic surgeries.

Top brands

Jupiter Hospitals with benchmark technologies e.g., ALLIA IGS 530 by GE HealthCare; flagship multi-speciality tertiary and quaternary care centers.

Recurring vs cyclical contribution

Revenue primarily from recurring patient services, elective surgeries, and healthcare treatments.

Our industry position

Leading multi-speciality hospital group in Western India, growing bed capacity and specialty care offerings with strong brand presence.

Financial highlights

FY 2025-26 consolidated revenue Rs.1,499.8 crores; net profit Rs.194 crores; steady revenue and profit growth year-on-year.

Whats driving growth

Rising healthcare demand, expansion into new locations, advanced treatments, medical tourism, and increased bed capacity drive growth.

Our future plans

Opening new hospitals in Bibvewadi Pune (500 beds) and Mira Road Thane (300 beds), expanding ICU and operating theatres.

Our people and values

Committed to patient-first philosophy, innovation, ethical governance, and employee professionalism.

Key challenges ahead

Managing expansion, maintaining high-quality care, regulatory compliance, and competitive healthcare landscape.

Interesting facts

First in India to install ALLIA IGS 530 by GE HealthCare; performed pioneering organ transplant surgeries in Thane.

Risks and strategy

Mitigates operational, financial and regulatory risks via strong governance, compliance, and continual monitoring.

Market Footprint

Top Clients

Top Clients

Serves diverse patients across multiple specialties, focusing on tertiary and quaternary care including medical tourists; B2C and healthcare institutions.

Top Products

Top Products

Advanced medical care in over 30 specialties including organ transplant, oncology, orthopaedics, cardiology, neurology, and precision treatments like robotic surgeries.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions